RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000071.xml
PDF herunterladen
Semin Neurol 2001; 21(3): 275-292
DOI: 10.1055/s-2001-17945
DOI: 10.1055/s-2001-17945
Neuro-ophthalmology of Mitochondrial Diseases
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
18. Oktober 2001 (online)
ABSTRACT
The afferent and efferent visual pathways within the central nervous system are frequently involved in mitochondrial diseases. Neuro-ophthalmic signs figure prominently and may be the presenting or even sole manifestation of these disorders. The four most common neuro-ophthalmic abnormalities seen in mitochondrial disorders are bilateral optic neuropathy, ophthalmoplegia with ptosis, pigmentary retinopathy, and retrochiasmal visual loss.
KEYWORD
Mitochondrial disease - optic neuropathy - Leber's hereditary optic neuropathy - ophthalmoplegia - CPEO - MELAS - pigmentary retinopathy - encephalopathy - homonymous hemianopia - cortical blindness
REFERENCES
- 1 DiMauro S, Bonilla E, Zeviani M. Mitochondrial myopathies. Ann Neurol . 1985; 17 521-538
- 2 Brown M D, Wallace D C. Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr . 1994; 26 273-289
- 3 Harding A E. Neurological disease and mitochondrial genes. Trends Neurosci . 1991; 14 132-138
- 4 Johns D R. Mitochondrial DNA and disease. N Engl J Med . 1995; 333 638-644
- 5 Riordan-Eva P. Neuro-ophthalmology of mitochondrial diseases. Curr Op Ophthalmol . 2000; 11 408-412
- 6 Newman N J. Mitochondrial disease and the eye. Ophthalmol Clin N Am . 1992; 5 405-424
- 7 Phillips P H, Newman N J. Mitochondrial diseases in pediatric ophthalmology. J AAPOS . 1997; 1 115-122
- 8 Munoz A, Mateos E, Simon R, Garcia-Silva M T, Cabello S, Arenas J. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology . 1999; 41 920-928
- 9 Zeviani M, Titanti V, Piantadosi C. Mitochondrial disorders. Medicine . 1998; 77 59-72
- 10 Wallace D C. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J . 2000; 139 S70-S85
- 11 Wallace D W. Mitochondrial diseases in man and mouse. Science . 1999; 283 1482-1488
- 12 Leonard J V, Schapira A HV. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet . 2000; 355 299-304
- 13 Leonard J V, Schapira A HV. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet . 2000; 355 389-394
- 14 Shoffner IV M J, Wallace D C. Oxidative phosphorylation diseases. Disorders of two genomes. Adv Hum Genet . 1990; 19 267-330
- 15 Shoffner J M, Wallace D C. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases
of Inherited Disease
7th ed. New York: McGraw-Hill 1995: 1535-1541
Reference Ris Wihthout Link
- 16 Harding A E. The mitochondrial genome: breaking the magic circle. N Engl J Med . 1989; 320 1341-1343
- 17 Holt I J, Harding A E, Cooper J M. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol . 1989; 26 699-708
- 18 Holt I J, Harding A E, Morgan-Hughes J A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature . 1988; 331 717-719
- 19 Chinnery P F, Howell N, Andrews R M, Turnbull D M. Mitochondrial DNA analysis: polymorphisms and pathogenicity. J Med Genet . 1999; 36 505-510
- 20 Wallace D C, Brown M D, Lott M T. Mitochondrial DNA variation in human evolution and disease. Gene . 1999; 238 211-230
- 21 Johns D R, Newman N J. Hereditary optic neuropathies. Semin Ophthalmol . 1995; 10 203-213
- 22 Newman N J. Hereditary optic neuropathies. In: Miller NR, Newman NJ, eds. Walsh & Hoyt Clinical Neuro-Ophthalmology
5th ed. Baltimore: Williams & Wilkins 1999: 741-773
Reference Ris Wihthout Link
- 23 Wallace D C, Singh G, Lott M T. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science . 1988; 242 1427-1430
- 24 Singh G, Lott M T, Wallace D C. A mitochondrial mutation as a cause of Leber's hereditary optic neuropathy. N Engl J Med . 1989; 320 1300-1305
- 25 Newman N J. Leber's hereditary optic neuropathy. Ophthalmol Clin North Am . 1991; 4 431-447
- 26 Newman N J. Leber's hereditary optic neuropathy: new genetic considerations. Arch Neurol . 1993; 50 540-548
- 27 Kerrison J B, Newman N J. Clinical spectrum of Leber's hereditary optic neuropathy. Clin Neurosci . 1997; 4 295-301
- 28 Thieme H, Wissinger B, Jandeck C. A pedigree of Leber's hereditary optic neuropathy with visual loss in childhood, primarily in girls. Graefe's Arch Clin Exp Ophthalmol . 1999; 237 714-719
- 29 Wakakura M, Yokoe J. Evidence for preserved direct pupillary light response in Leber's hereditary optic neuropathy. Br J Ophthalmol . 1995; 79 442-446
- 30 Bremner F D, Shallo-Hoffmann J, Riordan-Ava P, Smith S E. Comparing pupil function with visual function in patients with Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci . 1999; 40 2528-2534
- 31 Yoshitomi T, Matsui T, Tanakadate A, Ishikawa S. Comparison of threshold visual perimetry and objective perimetry in clinical patients. J Neuroophthalmol . 1999; 19 89-99
- 32 Jacobson D M, Stone E M, Miller N R. Relative afferent pupillary defects in patients with Leber hereditary optic neuropathy and unilateral visual loss. Ophthalmology . 1998; 126 291-295
- 33 Jun A S, Brown M D, Wallace D C. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A . 1994; 91 6206-6210
- 34 Nikoskelainen E K, Marttila R J, Huoponen K. Leber's ``plus'': neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry . 1995; 59 160-164
- 35 Shoffner J M, Brown M D, Stugard C. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol . 1995; 38 163-169
- 36 Ortiz R G, Newman N J, Manoukian S, Diesenhouse M C, Lott M T, Wallace D C. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber's hereditary optic neuropathy. Am J Ophthalmol . 1992; 113 561-566
- 37 Harding A E, Sweeney M G, Miller D H. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain . 1992; 115 979-989
- 38 Flanigan K M, Johns D R. Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology . 1993; 43 2720-2722
- 39 Keller-Wood H, Robertson N, Govan G G, Compston D AS, Harding A E. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol . 1994; 36 109-112
- 40 Olsen N K, Hansen A W, Norby S, Edal A L, Jorgensen J R, Rosenberg T. Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation. Acta Neurol Scand . 1995; 91 326-329
- 41 Bhatti M T, Newman N J. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol . 1999; 19 28-33
- 42 Carroll W M, Mastaglia F L. Leber's optic neuropathy: a clinical and visual evoked potential study of affected and asymptomatic members of a six generation family. Brain . 1979; 102 559-580
- 43 Livingstone I R, Mastaglia F L, Howe J W. Leber's optic neuropathy: clinical and visual evoked response studies in asymptomatic and symptomatic members of a 4-generation family. Br J Ophthalmol . 1980; 64 751-757
- 44 Barbiroli B, Montagna P, Cortelli P. Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation. Neurology . 1995; 45 1364-1369
- 45 Vaphiades M S, Newman N J. Optic nerve enhancement on orbital magnetic resonance imaging in Leber's hereditary optic neuropathy. J Neuroophthalmol . 1999; 19 238-239
- 46 Larsson N G, Andersen O, Holme E. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol . 1991; 30 701-708
- 47 Brown M D, Wallace D C. Spectrum of mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Clin Neurosci . 1994; 2 138-145
- 48 Nikoskelainen E K, Savontaus M L, Wanne O P. Leber's hereditary optic neuroretinopathy, a maternally inherited disease: a genealogic study in four pedigrees. Arch Ophthalmol . 1987; 105 665-671
- 49 Newman N J, Lott M T, Wallace D C. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol . 1991; 111 750-762
- 50 Hotta Y, Fujiki K, Hayakawa M. Clinical features of Japanese Leber's optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol . 1995; 39 96-108
- 51 Nikoskelainen E K, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus M L. Ophthalmologic findings in Leber hereditary optic neuropathy with special reference to mtDNA mutations. Ophthalmology . 1996; 103 504-514
- 52 Riordan-Eva P, Harding A E. Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. J Med Genet . 1995; 32 81-87
- 53 Mackey D A. Epidemiology of Leber's hereditary optic neuropathy in Australia. Clin Neurosci . 1994; 2 162-164
- 54 Mackey D A. Three subgroups of patients from the United Kingdom with Leber hereditary optic neuropathy. Eye . 1994; 8 431-436
- 55 Mackey D, Buttery R G. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol . 1992; 20 177-184
- 56 Riordan-Eva P, Sanders M D, Govan G G, Sweeney M G, Da Costa J, Harding A E. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain . 1995; 118 319-337
- 57 Mashima Y, Yamada K, Wakakura M. Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy. Curr Eye Research . 1998; 17 403-408
- 58 Howell N, Kubacka I, Xu M. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet . 1991; 48 935-942
- 59 Brown M D, Voljavec A S, Lott M T. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics . 1992; 130 163-173
- 60 Johns D R, Berman J. Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Biochem Biophys Res Commun . 1991; 74 1324-1330
- 61 Johns D R, Neufeld M J. Cytochrome b mutations in Leber hereditary optic neuropathy. Biochem Biophys Res Commun . 1991; 181 1358-1364
- 62 Johns D R, Neufeld M J. Cytochrome c oxidase mutations in Leber hereditary optic neuropathy. Biochem Biophys Res Commun . 1993; 196 810-815
- 63 Howell N, Bindoff L A, McCullough D A. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet . 1991; 49 939-950
- 64 Huoponen K, Vilkki J, Aula P. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet . 1991; 48 1147-1153
- 65 Johns D R, Smith K H, Miller N R. Leber's hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol . 1992; 110 1577-1581
- 66 Cock H R, Tabrizi S J, Cooper J M, Shapira A H. The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy. Ann Neurol . 1998; 44 187-193
- 67 Cock H R, Cooper J M, Shapira A H. Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. J Neurol Sci . 1999; 165 10-17
- 68 Johns D R, Heher K L, Miller N R, Smith K H. Leber's hereditary optic neuropathy: clinical manifestations of the 14484 mutation. Arch Ophthalmol . 1993; 111 495-498
- 69 Macmillan C, Johns T A, Fu K, Shoubridge E A. Predominance of the 14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect. Am J Hum Genet . 2000; 66 332-333
- 70 Johns D R, Neufeld M J, Park R D. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun . 1992; 187 1551-1557
- 71 Lamminen T, Majander A, Juvonen V. A mitochondrial mutation at nt9101 in the ATP synthase 6 gene associated with deficient oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy. Am J Hum Genet . 1995; 56 1238-1240
- 72 Besch D, Leo-Klotter B, Zrenner E, Wissinger B. Leber's hereditary optic neuropathy: clinical and molecular genetic findings in a patient with a new mutation in the ND6 gene. Graefe's Arch Clin Exp Ophthalmol . 1999; 237 745-752
- 73 Carelli V, Ghelli A, Bucchi L. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann Neurol . 1999; 45 320-328
- 74 Nakamura M, Ara F, Yamada M. High frequency of mitochondrial ND4 gene mutation in Japanese pedigrees with Leber hereditary optic neuropathy. Jpn J Ophthalmol . 1992; 36 56-61
- 75 Johns D R, Smith K H, Savino P J, Miller N R. Leber's hereditary optic neuropathy: clinical manifestations of the 15257 mutation. Ophthalmology . 1993; 100 981-986
- 76 Matsumoto M, Hayasaka S, Kadoi C. Secondary mutations of mitochondrial DNA in Japanese patients with Leber hereditary optic neuropathy. Ophthalmic Genet . 1999; 20 153-160
- 77 Brown M D, Voljavec A S, Lott M T. Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases. FASEB J . 1992; 6 2791-2799
- 78 Brown M D. The enigmatic relationship between mitochondrial dysfunction and Leber's hereditary optic neuropathy. J Neurol Sci . 1999; 65 1-5
- 79 Went L N. Leber hereditary optic neuropathy (LHON): a mitochondrial disease with unresolved complexities. Cytogenet Cell Genet . 1999; 86 153-156
- 80 Brown M D, Sun F, Wallace D C. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 4484 mutations on an mtDNA lineage. Am J Hum Genet . 1997; 60 381-387
- 81 Torroni A, Petrozzi M, D'Urbano L. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet . 1997; 60 1107-1121
- 82 Oostra R J, Bolhuis P A, Wijburg F A, Zorn-Ende G, Bleeker-Wagemakers E M. Leber's hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome. J Med Genet . 1994; 31 280-286
- 83 Nakamura M, Yamamoto M. Variable pattern of visual recovery of Leber's hereditary optic neuropathy. Br J Ophthalmol . 2000; 84 534-535
- 84 Swartz N, Savino P J. Is all nondefinable optic atrophy Leber's hereditary optic neuropathy?. Surv Ophthalmol . 1994; 39 146-150
- 85 Weiner N C, Newman N J, Lessell S, Johns D R, Lott M T, Wallace D C. Atypical Leber's hereditary optic neuropathy with molecular confirmation. Arch Neurol . 1993; 50 470-473
- 86 Smith K H, Johns D R, Heher K L, Miller N R. Heteroplasmy in Leber's hereditary optic neuropathy. Arch Ophthalmol . 1993; 111 1486-1490
- 87 DuBois L G, Feldon S E. Evidence for a metabolic trigger for Leber's hereditary optic neuropathy: a case report. J Clin Neuroophthalmol . 1992; 12 15-16
- 88 Cullom M E, Heher K L, Miller N R, Savino P J, Johns D R. Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol . 1993; 111 1482-1485
- 89 Chalmers R M, Harding A E. A case-control study of Leber's hereditary optic neuropathy. Brain . 1996; 119 1481-1486
- 90 Tsao K, Aitken P A, Johns D R. Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br J Ophthalmol . 1999; 83 577-581
- 91 Kerrison J B, Miller N R, Hsu F C. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol . 2000; 130 803-812
- 92 Mackey D A, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet . 1992; 51 1218-1228
- 93 Taylor R W, Birch-Machin M A, Schaefer J. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann Neurol . 1996; 39 224-232
- 94 Fang W, Huang C C, Lee C C, Cheng S Y, Pang C Y, Wei Y H. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol . 1993; 50 977-980
- 95 Pulkes T, Eunson L, Patterson V. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Ann Neurol . 1999; 46 916-919
- 96 Petty R K, Harding A E, Morgan-Hughes J A. The clinical features of mitochondrial myopathy. Brain . 1986; 109 915-938
- 97 Drachman D A. Ophthalmoplegia plus: the neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol . 1968; 18 654-674
- 98 Kuncl R W, Hoffman P N. Myopathies and disorders of neuromuscular transmission. In: Miller NR, Newman NJ, eds. Walsh & Hoyt Clinical Neuro-Ophthalmology
5th ed. Baltimore: Williams & Wilkins 1999: 1351-1460
Reference Ris Wihthout Link
- 99 Berenberg R A, Pellock J M, DiMauro S. Lumping or splitting?. <~>``Ophthalmoplegia-plus'' or Kearns-Sayre syndrome? Ann Neurol . 1977; 1 37-54
- 100 Oldfors A, Fyhr I M, Holme E, Larsson N G, Tulinius M. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol . 1990; 80 541-546
- 101 Wray S H, Provenzale J M, Johns D R, Thulborn K R. MR of the brain in mitochondrial myopathy. AJNR . 1993; 16 1167-1173
- 102 Chu B C, Terae S, Takayashi C. MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology . 1999; 41 759-764
- 103 Clark D S, Myerburg R J, Morales A R, Befeler B, Hernandez F A, Gelband H. Heart block in Kearns-Sayre syndrome. Chest . 1975; 68 727-730
- 104 Lestienne P, Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet . 1988; 1 885
- 105 Zeviani M, Moraes C T, DiMauro S. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology . 1988; 38 1339-1346
- 106 Shoffner J M, Lott M T, Voljavec A S. Spontaneous Kearns-Sayre chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A . 1989; 86 7952-7956
- 107 Moraes C T, DiMauro S, Zeviani M. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med . 1989; 320 1293-1299
- 108 Shanske S, Moraes C T, Lombes A. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology . 1990; 40 24-28
- 109 Degoul F, Nelson I, Lestienne P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome and ocular myopathies: genetic, biochemical and morphological studies. J Neurol Sci . 1991; 101 168-177
- 110 Silvestri G, Servidei S, Rana M. A novel mitochondrial DNA point mutation in the tRNAlle gene is associated with progressive external ophthalmoplegia. Biochem Biophys Res Commun . 1996; 220 623-627
- 111 DiMauro S. Mitochondrial encephalomyopathies: back to Mendelian genetics. Ann Neurol . 1999; 45 693-694
- 112 Zeviani M, Servidei S, Gellera C. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature . 1989; 339 309-311
- 113 Servidei S, Zeviani M, Manfredi G. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology . 1991; 41 1053-1059
- 114 Suomalainen A, Kaukonen J, Amati P. An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet . 1995; 9 146-151
- 115 Kaukonen J A, Amati P, Suomalainen A. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet . 1996; 58 763-769
- 116 Suomalainen A, Majander A, Wallin M. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology . 1997; 48 1244-1253
- 117 Li F Y, Tariq M, Croxen R. Mapping of autosomal dominant progressive external ophthalmoplegia to 1 to 7-cM critical region on 10q24. Neurology . 1999; 53 1265-1271
- 118 Moslemi A R, Melberg A, Holme E, Oldfors A. Autosomal dominant progressive external ophthalmoplegia: distribution of multiple mitochondrial DNA deletions. Neurology . 1999; 53 79-84
- 119 Bohlega S, Tanji K, Santorelli F M, Hirano M, al-Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology . 1996; 46 1329-1334
- 120 Zupanc M L, Moraes C T, Shanske S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol . 1991; 29 680-683
- 121 Hirano M, Silvestri G, Blake D M. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology . 1994; 44 721-727
- 122 Nishino I, Spinazzola A, Papadimitriou A. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol . 2000; 47 792-800
- 123 Mullie M A, Harding A E, Petty R KH. The retinal manifestations of mitochondrial myopathy. Arch Ophthalmol . 1985; 103 1825-1830
- 124 Isashiki Y, Nakagawa M, Ohba N. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutations. Acta Ophthalmol Scand . 1998; 76 6-13
- 125 Sue C M, Mitchell P, Crimmins D S, Moshegov C, Byrne E, Morris J GL. Pigmentary retinopathy associated with the mitochondrial DNA 3242 point mutation. Neurology . 1997; 49 1013-1017
- 126 Latkany P, Ciulla T A, Cacchillo P F, Malkoff M D. Mitochondrial maculopathy: geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation. Am J Ophthalmol . 1999; 128 112-114
- 127 Smith P R, Bain S R, Good P A. Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNAleu A to G mutation. Ophthalmology . 1999; 106 1101-1108
- 128 Massin P, Guillausseau P J, Vialettes B. Macular pattern dystrophy associated with a mutation of mitochondrial DNA. Am J Ophthalmol . 1995; 120 247-248
- 129 Massin P, Virally-Monod M, Vialettes B. Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. Ophthalmology . 1999; 106 1821-1827
- 130 Ortiz R G, Newman N J, Shoffner J M, Kaufman A E, Koontz D A, Wallace D C. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol . 1993; 111 1525-1530
- 131 Kerrison J B, Biousse V, Newman N J. Retinopathy of NARP syndrome. Arch Ophthalmol . 2000; 118 298-299
- 132 Rahman S, Blok R B, Dahl H H. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol . 1996; 39 343-351
- 133 Sakuta R, Goto Y, Horai S. Mitochondrial DNA mutation and Leigh's syndrome. Ann Neurol . 1992; 32 597-598
- 134 Santorelli F M, Shanske S, Macaya A, DeVivo D C, DiMauro S. The mutation at nt8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol . 1993; 34 827-834
- 135 Santorelli F M, Tanji M, Shanske S. Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology . 1997; 49 270-273
- 136 Tatuch Y, Christodoulou J, Feigenbaum A. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet . 1992; 50 852-858
- 137 Shoffner J M, Fernhoff P M, Krawiecki N S. Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology . 1992; 42 2168-2174
- 138 Pavlakis S G, Phillips P C, DiMauro S. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol . 1984; 16 481-488
- 139 Ciafaloni E, Ricci E, Shanske S. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol . 1992; 31 391-398
- 140 Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup in mitochondrial encephalomyopathies. Nature . 1990; 348 651-653
- 141 Goto Y, Nonaka I, Horai S. A new mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta . 1991; 1097 238-240
- 142 Goto Y, Horai S, Matsuoka T. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology . 1992; 42 545-550
- 143 Matthews P M, Tampieri D, Berkovic S F. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology . 1991; 41 1043-1046
- 144 Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology . 1999; 53 2182-2184
- 145 Kaufmann P, Koga Y, Shanske S. Mitochondrial DNA and RNA processing in MELAS. Ann Neurol . 1996; 40 172-180